Vol 28, No 6 (2021)
Research Letter
Published online: 2021-09-10
Atrial fibrillation is related to higher mortality in COVID-19/SARS-CoV-2 pneumonia infection
Abstract
Not available
References
- https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200928-weekly-epi-update.pdf?sfvrsn=9e354665_6.
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497–506.
- Elias P, Poterucha TJ, Jain SS, et al. The prognostic value of electrocardiogram at presentation to emergency department in patients with COVID-19. Mayo Clin Proc. 2020; 95(10): 2099–2109.
- Denegri A, Pezzuto G, D'Arienzo M, et al. Clinical and electrocardiographic characteristics at admission of COVID-19/SARS-CoV2 pneumonia infection. Intern Emerg Med. 2021; 16(6): 1451–1456.
- Bertini M, Ferrari R, Guardigli G, et al. Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement. Europace. 2020; 22(12): 1848–1854.
- Pardo Sanz A, Salido Tahoces L, Ortega Pérez R, et al. New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis. Cardiol J. 2021; 28(1): 34–40.
- Sanchis-Gomar F, Perez-Quilis C, Lavie CJ. Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients? Eur Heart J. 2020; 41(32): 3092–3093.
- Ruocco G, McCullough PA, Tecson KM, et al. Mortality risk assessment using CHA(2)DS(2)-VASc scores in patients hospitalized with coronavirus disease 2019 infection. Am J Cardiol. 2020; 137: 111–117.